文献速递神经免疫

鞘内IgM生成是早期转化为多发性硬化的重要风险因素

Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis.
PubMed 文献 · Neurology · 2019-09-09

这项前瞻性研究纳入150例临床孤立综合征或早期多发性硬化患者,评估鞘内IgM生成相较于已知风险因素对转化为多发性硬化的预测价值。多变量Cox回归显示,鞘内IgM生成与临床孤立综合征患者转化为多发性硬化强烈相关(HR 3.05,95%CI 1.45-6.44,p=0.003),且独立于年龄、寡克隆带、鞘内IgG生成和空间多发影像学证据。

要点

  • 鞘内IgM生成见于23.2%的临床孤立综合征/早期多发性硬化患者。
  • 鞘内IgM生成者发病年龄平均年轻5岁且幕下病灶更常见。
  • 鞘内IgM生成是临床孤立综合征早期转化为多发性硬化的独立风险因素。

核心结论

  • 鞘内IgM生成是早期转化为多发性硬化的强烈独立风险因素,可能作为预测临床孤立综合征患者未来疾病活动的临床有意义标志物。

研究设计与样本

  • 前瞻性研究纳入150例临床孤立综合征/早期多发性硬化患者,收集全面脑脊液数据(包括寡克隆IgG带和计算的鞘内IgM/IgG生成),并进行规律临床和MRI评估。

主要发现

  • 鞘内IgM生成>0%见于23.2%(33/142)的患者,其发病年龄平均年轻5岁(p=0.013)。
  • 鞘内IgM生成者幕下病灶更常见(18/32,56.3%),而无鞘内IgM生成者为33/104(31.7%),p=0.021。
  • 在临床孤立综合征患者(n=93,中位临床和MRI随访分别为24和21个月)中,调整年龄、寡克隆带、鞘内IgG生成和空间多发影像学证据后,鞘内IgM生成与按McDonald 2010标准转化为多发性硬化强烈相关(HR 3.05,95%CI 1.45-6.44,p=0.003)。
  • 调整变量中,年龄(HR 0.96,95%CI 0.93-1.00,p=0.059)、寡克隆带(HR 0.92,95%CI 0.33-2.61,p=0.879)、鞘内IgG生成(HR 0.98,95%CI 0.48-1.99,p=0.947)和空间多发影像学证据(HR 2.63,95%CI 1.11-6.22,p=0.028)。

关键数值与推荐

  • 鞘内IgM生成>0%定义为阳性,见于23.2%(33/142)的患者。
  • 临床孤立综合征患者中,鞘内IgM生成与转化为多发性硬化的HR为3.05(95%CI 1.45-6.44,p=0.003)。
  • 空间多发影像学证据与转化为多发性硬化的HR为2.63(95%CI 1.11-6.22,p=0.028)。

临床怎么用

  • 对临床孤立综合征患者检测鞘内IgM生成有助于识别早期转化为多发性硬化高风险者,可辅助预测未来疾病活动。

局限性

  • 研究样本量有限(150例),临床孤立综合征亚组仅93例,随访时间中位24个月,结论需更大队列验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate intrathecal immunoglobulin M (IgM) production, as compared to previously established risk factors, as risk factor for conversion from clinically isolated syndrome (CIS) to multiple sclerosis (MS) and to explore the association of intrathecal IgM production with onset age and radiologic and CSF findings in CIS/early MS. METHODS: Comprehensive CSF data, including oligoclonal immunoglobulin G (IgG) bands (OCB) and calculated intrathecal IgM and IgG production, were collected in a prospective study of 150 patients with CIS/early MS with regular clinical and MRI assessments. RESULTS: Intrathecal IgM production >0% occurred in 23.2% (33/142) of patients, who were on average 5 years younger at disease onset (p = 0.013) and more frequently had infratentorial lesions (18/32, 56.3%) than patients without intrathecal IgM production (33/104, 31.7%, p = 0.021). In multivariable Cox regression analyses, intrathecal IgM production in patients with a CIS (n = 93, median clinical and MRI follow-up 24 and 21 months) was strongly associated with conversion to MS according to the McDonald 2010 criteria (hazard ratio [95% confidence interval] 3.05 [1.45-6.44], p = 0.003) after adjustment for age (0.96 [0.93-1.00], p = 0.059), OCB (0.92 [0.33-2.61], p = 0.879), intrathecal IgG production (0.98 [0.48-1.99], p = 0.947), and radiologic evidence of dissemination in space (2.63 [1.11-6.22], p = 0.028). CONCLUSION: Intrathecal IgM production is a strong independent risk factor for early conversion to MS and may thus represent a clinically meaningful marker for predicting future disease activity in patients with a CIS.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Pfuhl C, Grittner U, Gieß RM, et al. Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis. Neurology. 2019. PMID: 31501228. doi:10.1212/WNL.0000000000008237

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。